Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids
- 11 December 2009
- Vol. 65 (1), 109-116
- https://doi.org/10.1111/j.1398-9995.2009.02142.x
Abstract
Background: Esophageal remodeling occurs in eosinophilic esophagitis (EE) patients but whether the components of remodeling in the subepithelium are reversible by administration of topical oral corticosteroids is unknown. Methods: We quantitated the degree of lamina propria remodeling in esophageal biopsies obtained before and after at least 3 months of therapy with budesonide in 16 pediatric EE subjects. In addition, we investigated whether corticosteroid therapy modulated vascular activation (expression of VCAM-1; level of interstitial edema), TGFβ1 activation (levels of TGFβ1, phosphorylated Smad2/3), and performed a pilot analysis of a polymorphism in the TGFβ1 promoter in relation to EE subjects who had reduced remodeling with budesonide therapy. Results: EE subjects were stratified based on the presence (n = 9) or absence (n = 7) of decreased epithelial eosinophilia following budesonide. Patients with residual eosinophil counts of ≤7 eosinophils per high power field in the epithelial space (responders) demonstrated significantly reduced esophageal remodeling with decreased fibrosis, TGFβ1 and pSmad2/3 positive cells, and decreased vascular activation in association with budesonide therapy. Responders were more likely to have a CC genotype at the −509 position in the TGFβ1 promoter. Conclusions: Reductions in epithelial eosinophils following budesonide therapy were associated with significantly reduced esophageal remodeling.Keywords
This publication has 18 references indexed in Scilit:
- Eosinophilic Esophagitis: A Prevalent Disease in the United States That Affects All Age GroupsGastroenterology, 2008
- TGFB1 promoter polymorphism C-509T and pathophysiology of asthmaJournal of Allergy and Clinical Immunology, 2008
- Immunologic and inflammatory mechanisms that drive asthma progression to remodelingJournal of Allergy and Clinical Immunology, 2008
- Comparison of Oral Prednisone and Topical Fluticasone in the Treatment of Eosinophilic Esophagitis: A Randomized Trial in ChildrenClinical Gastroenterology and Hepatology, 2008
- Esophageal Remodeling Develops as a Consequence of Tissue Specific IL-5-Induced EosinophiliaGastroenterology, 2008
- Eosinophilic Esophagitis in Children and Adults: A Systematic Review and Consensus Recommendations for Diagnosis and Treatment: Sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and NutritionGastroenterology, 2007
- Distinguishing Eosinophilic Esophagitis in Pediatric PatientsJournal of Clinical Gastroenterology, 2007
- A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate for Pediatric Eosinophilic EsophagitisGastroenterology, 2006
- Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patientsJournal of Allergy and Clinical Immunology, 2006
- Transforming Growth Factor-β1 SNPs: Genetic and Phenotypic Correlations in Progressive Kidney InsufficiencyNephron Experimental Nephrology, 2005